Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure

Table 2 Univariate logistic analysis for survival probability

Variables	Estimate	P	Lower 95%	Upper 95%	Odds ratio
Age (50 vs ≤ 50 yr)	-0.6061	0.0912	-0.0802	1.3415	3.3608
Sex (male vs female)	0.1247	0.7244	-0.5708	0.8322	1.2833
Ascites (none vs present)	1.2079	0.0036	0.4465	2.1030	11.1997
Encephalopathy (none vs present)	0	1.0000	-0.6799	0.6799	1
T.Bil (< 8 mg/dL vs ≥ 8)	0.4745	0.4930	-0.8767	1.8627	1.6071
D/T. Bil ratio (> 0.65 vs ≤ 0.65)	0.4884	0.4870	-0.8825	1.9022	1.6296
Albumin (> 3.3 vs ≤ 3.3 g/dL)	1.4816	0.0440	0.0865	3.0029	4.4000
ChE (> 100 vs ≤ 100 mg/dL)	0.8574	0.2306	-0.5244	2.3092	2.3571
AST (> 3500 vs ≤ 3500 U/L)	0.4745	0.4930	-0.8767	1.8627	1.6071
ALT (> 4000 vs ≤ 4000 U/L)	0.9628	0.1735	-0.3993	2.4025	2.6190
AST/ALT ratio (> 1 vs ≤ 1)	0.2356	0.7317	-1.1151	1.6042	1.2656
LDH (> 600 vs ≤ 600 U/L)	1.2122	0.0912	-0.1603	2.6831	3.3608
PT-INR (> 2 vs ≤ 2)	1.4816	0.0440	0.0865	3.0029	20.1446
Platelet (>12 × 104/μL vs ≤ 12 × 104)	1.7509	0.0200	0.3335	3.3197	5.7600
AFP (< 5 vs ≥ 5 ng/mL)	0.2356	0.7317	-1.1151	1.4616	1.2656
NH3 (< 55 vs ≥ 55 μg/mL)	0.2356	0.7317	-1.1151	1.6042	1.2656
BUN (< 10 vs ≥ 10 mg/dL)	0.2356	0.7317	-1.1151	1.6042	1.2656
Etiology
HBV (vs HAV)	0.3269	0.5761	-0.8196	1.5405	1.9230
Others (vs HAV)	0.1446	0.7567	-0.7763	1.0744	1.3354
TASIT (yes vs no)	1.1787	0.0036	0.4311	2.0387	10.5624